Current status of percutaneous transluminal angioplasty.

With the development of a dilating balloon catheter that permits percutaneous treatment of many arterial stenoses and some occlusions, a definite advance in the therapy of peripheral vascular disease has been made. It is still too early to be certain what ultimate position this means of therapy will take in the overall treatment of vascular disease, as its use is still being extended and long-term results are not yet clearly known. When compared with surgical therapy, however, it has some striking advantages, although the durability of its effect appears to be less. Despite the fact that more time and experience are needed before its ultimate position is established, we believe that the evidence to date warrants inclusion of this form of therapy in the armamentarium of every major vascular center.